Less risk of esophageal bleed with rifaximin

CHICAGO – Patients with cirrhosis and medium to large esophageal varices were 81% less likely to develop a first esophageal variceal bleed within 5 years if they took rifaximin to manage hepatic...

Field of Interest: Gastroentero...
Type: News Item

FISH panel may improve Barrett’s surveillance

CHICAGO – Fluorescence in situ hybridization testing for aneuploidy and loss of the tumor suppressor gene P16 can be useful in predicting progression to high-grade dysplasia and adenocarcinoma in...

Field of Interest: Gastroentero...
Type: News Item

Larazotide eased symptoms in phase II celiac trial

CHICAGO – Larazotide acetate, a first-in-class oral medication developed specifically to treat celiac disease, reduced both gastrointestinal and non-GI symptoms in patients who were symptomatic...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness